1. P12 A FeNO-based strategy to guide oral corticosteroid initiation in patients with severe asthma experiencing an exacerbation whilst on treatment with anti-IL5/5R therapy. (11th November 2022) Authors: Lam, JL; Hearn, AP; Thomson, LA; Green, LM; Fernandes, M; Roxas, C; D'Ancona, G; Dhariwal, J; Nanzer, AM; Jackson, DJ Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P13 T2 biomarker-guided oral corticosteroid weaning in asthma. (11th November 2022) Authors: Thomson, LA; Hearn, AP; Lam, JL; Fernandes, M; Green, LM; Roxas, C; D'Anconna, G; Dhariwal, J; Nanzer, AM; Jackson, DJ Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P210 The impact of introducing anti-IL-5/5R biologic therapies on weight and BMI in prednisolone-dependent patients with severe asthma. (11th November 2022) Authors: Taylor, VM; Patrick, T; Hearn, AP; Kavanagh, JE; Thomson, LA; Lam, JL; Green, LM; Fernandes, M; Roxas, C; d'Ancona, G; Dhariwal, J; Jackson, DJ; Nanzer, AM Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S129 Change in FeNO as a biomarker of response to anti-IL5/5R therapies in severe asthma. (11th November 2022) Authors: Hearn, AP; Kavanagh, JE; Dhariwal, J; Nanzer, AM; Jackson, DJ Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗